Co-Diagnostics, Inc. Contracts & Agreements
46 Contracts & Agreements
- Business Finance (26 contracts)
- Business Operations (1)
- Human Resources (2)
- Intellectual Property (1)
- Mergers & Acquisitions (4)
- Real Estate (5)
- Uncategorized (7)
- Description of Registrants securities (Filed With SEC on March 14, 2024)
- Commercial Lease Agreement, dated September 18, 2023, between Ge Estate, LLC and Co-Diagnostics, Inc (Filed With SEC on November 9, 2023)
- Commercial Lease Agreement, dated June 1, 2023, between Ozone Biotech, LLC and Co-Diagnostics, Inc (Filed With SEC on August 10, 2023)
- Co-Diagnostics, Inc. Change in Control Severance Plan (Filed With SEC on May 16, 2023)
- Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Advanced Conceptions, Inc., and Richard Abbott, as Company Representative (Filed With SEC on June 16, 2022)
- Amendment to Agreement and Plan of Merger by and among Co-Diagnostics, Inc., Idaho Molecular, Inc., and Kirk Ririe, as Company Representative (Filed With SEC on June 16, 2022)
- Description of Registrants securities (Filed With SEC on March 24, 2022)
- Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (ACI Warrant) (Filed With SEC on March 24, 2022)
- Warrant Agreement between Co-Diagnostics, Inc and VStock Transfer, LLC. Dated December 31, 2021 (IDMO Warrant) (Filed With SEC on March 24, 2022)
- Lease Agreement 2401 Foothill Drive (Filed With SEC on March 24, 2022)
- Amendment #1 to Lease (Filed With SEC on March 24, 2022)
- Amendment #2 to Lease (Filed With SEC on March 24, 2022)
- Agreement and Plan of Merger by and between Co-Diagnostics, Inc, IDMO Acquisition Corp., Idaho Molecular Inc., and Company Representative dated as of December 21, 2021 (Filed With SEC on December 23, 2021)
- Agreement and Plan of Merger by and between Co-Diagnostics, Inc, ACI Acquisition Corp., Advanced Conceptions, Inc., and Company Representative dated as of December 21, 2021 (Filed With SEC on December 23, 2021)
- Description of Registrants securities (Filed With SEC on March 25, 2021)
- Form of Securities Purchase Agreement, dated February 27, 2020 (Filed With SEC on February 27, 2020)
- Form of Securities Purchase Agreement, dated February 10, 2020 (Filed With SEC on February 11, 2020)
- Form of Securities Purchase Agreement, dated January 23, 2020 (Filed With SEC on January 27, 2020)
- Form of Second Amendment Agreement (Filed With SEC on April 1, 2019)
- Form of Securities Purchase Agreement, dated January 31, 2019, for the Common Stock (Filed With SEC on February 4, 2019)
- Form of Securities Purchase Agreement, dated January 30, 2019, for the Preferred Stock (Filed With SEC on February 4, 2019)
- 9% Promissory Note, dated August 3, 2018, between Co-Diagnostics, Inc. and Robert Salna for $2,000,000 (Filed With SEC on August 9, 2018)
- Underwriting Agreement dated July 12, 2017 (Filed With SEC on July 13, 2017)
- Form of Second Amendment Agreement (Filed With SEC on July 10, 2017)
- Form of Amendment Agreement (Filed With SEC on June 23, 2017)
- UNDERWRITING AGREEMENT among CO-DIAGNOSTICS, INC. and WALLACHBETH Capital, LLC and NETWORK 1 FINANCIAL SECURITIES, INC., as Representatives of the Several Underwriters (Filed With SEC on June 9, 2017)
- Form Second Amendment to 12% Revolving Line of Credit Promissory Note Due 2017 between Co-Diagnostics, Inc. and Turks and Caicos Limited Company, Pine Valle Investments, LLC,... (Filed With SEC on May 24, 2017)
- Underwriting Agreement (Filed With SEC on May 24, 2017)
- Form of Indemnification Agreement (Filed With SEC on May 24, 2017)
- 10% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- CO-DIAGNOSTICS, INC. 2015 LONG TERM INCENTIVE PLAN 1. GENERAL (Filed With SEC on April 28, 2017)
- CO-DIAGNOSTICS, INC. PROSPERITY INVESTMENTS SUBSCRIPTION AGREEMENT (Filed With SEC on April 28, 2017)
- MUTUAL RESCISSION AGREEMENT (Filed With SEC on April 28, 2017)
- NON-INTEREST BEARING NOTE DUE 2020 (Filed With SEC on April 28, 2017)
- STOCK PURCHASE AGREEMENT (Filed With SEC on April 28, 2017)
- AMENDED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on April 28, 2017)
- SHAREHOLDERS AGREEMENT (Filed With SEC on April 28, 2017)
- 12% CONVERTIBLE NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- 8.5% CONVERTIBLE NOTE DUE 2017 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSORY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROMISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- AMENDMENT TO 12% REVOLVING LINE OF CREDIT PROIVIISSOPRY NOTE DUE 2016 OF CO-DIAGNOSTICS, INC. (Filed With SEC on April 28, 2017)
- REVOLVING LINE OF CREDIT PROMISSORY NOTE (Filed With SEC on April 28, 2017)
